Patents by Inventor Julie Liu

Julie Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydroisoquinoline derivatives
    Patent number: 8084464
    Abstract: This invention relates to novel tetrahydroisoquinoline derivatives, their derivatives, pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a dual OX-1/OX-2 orexin antagonist.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: December 27, 2011
    Assignee: CoNCERT Pharmaceuticals, Inc.
    Inventor: Julie Liu
  • 2-OXO-1-PYRROLIDINE DERIVATIVES
    Publication number: 20110212944
    Abstract: This invention relates to novel 2-oxo-1-pyrrolidines, their derivatives, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a compound with the ability to act as a synaptic vesicle protein 2A (SV2A) ligand and/or a sodium channel blocker.
    Type: Application
    Filed: June 30, 2009
    Publication date: September 1, 2011
    Inventors: Julie Liu, Rose Persichetti
  • LIQUID PHARMACEUTICAL FORMULATIONS OF DOCETAXEL
    Publication number: 20110152360
    Abstract: There is provided a liquid pharmaceutical formulation for parenteral administration comprising: docetaxel or a pharmaceutically acceptable salt thereof; one or more glycols; and a pharmaceutically acceptable nonaqueous solvent system; wherein the formulation has a pH meter reading in the range of from 2.5 to 7.
    Type: Application
    Filed: March 2, 2011
    Publication date: June 23, 2011
    Applicant: HOSPIRA AUSTRALIA PTY LTD.
    Inventors: Aikun Julie Liu, Allan Harvey Spencer, Andrew Malcolm Knill, Daniel David Ash
  • ACID CONTAINING OXALIPLATIN FORMULATIONS
    Publication number: 20100063145
    Abstract: There is provided a pharmaceutical liquid formulation of oxaliplatin for parenteral administration, said formulation having (i) oxaliplatin; (ii) water; and (iii) an acid wherein the acid is stabilising and is not malonic acid, lactic acid or oxalic acid. Methods of preparing the formulation are also disclosed. There is further provided the use of the formulation in the preparation of a medicament for the treatment of cancer and a method for treating cancer which comprises administering a therapeutic amount of a pharmaceutical formulation.
    Type: Application
    Filed: October 19, 2009
    Publication date: March 11, 2010
    Inventors: Darryl Vanstone Whittaker, Aikun Julie Liu
  • OXALIPLATIN FORMULATIONS
    Publication number: 20100035982
    Abstract: The present invention provides a pharmaceutical liquid formulation of oxaliplatin for parenteral administration, said formulation having (i) oxaliplatin, (ii) water; and (iii) an additive selected from the group of tartaric acid, a salt of tartaric acid, a pharmaceutically acceptable derivative of tartaric acid and mixtures thereof.
    Type: Application
    Filed: October 19, 2009
    Publication date: February 11, 2010
    Inventors: Darryl Vanstone Whittaker, Aikun Julie Liu
  • TETRAHYDROISOQUINOLINE DERIVATIVES
    Publication number: 20090192188
    Abstract: This invention relates to novel tetrahydroisoquinoline derivatives, their derivatives, pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a dual OX-1/OX-2 orexin antagonist.
    Type: Application
    Filed: December 18, 2008
    Publication date: July 30, 2009
    Inventor: Julie Liu
  • Liquid Pharmaceutical Formulations of Docetaxel
    Publication number: 20090118354
    Abstract: There is provided a liquid pharmaceutical formulation for parenteral administration comprising: docetaxel or a pharmaceutically acceptable salt thereof; one or more glycols; and a pharmaceutically acceptable nonaqueous solvent system; wherein the formulation has a pH meter reading in the range of from 2.5 to 7.
    Type: Application
    Filed: June 16, 2006
    Publication date: May 7, 2009
    Applicant: MAYNE PHARMA LIMITED
    Inventors: Aikun Julie Liu, Allan Harvey Spencer, Andrew Malcolm Knill, Daniel David Ash
  • Alpha carbolines and uses thereof
    Publication number: 20070207997
    Abstract: This invention provides alpha-carboline compounds of formula I: wherein R1, R2, R3, R4, R5, and x are as described in the specification. The compounds are useful for treating inflammatory diseases and cancer.
    Type: Application
    Filed: February 15, 2007
    Publication date: September 6, 2007
    Inventors: Michael Hepperle, Julie Liu, R. Rowland, Dilrukshi Vitharana
  • Beta-carbolines useful for treating inflammatory disease
    Publication number: 20050239781
    Abstract: This invention provides beta-carboline compounds of formula III-A-aa: wherein Q, G, R1, R2, R3, and R6b are as described in the specification. The compounds are useful for treating diseases such as inflammatory diseases and cancer.
    Type: Application
    Filed: April 8, 2005
    Publication date: October 27, 2005
    Inventors: Michael Hepperle, Julie Liu, Francois Soucy, Prakash Raman, Jeremy Little, Paul Fleming, Dominic Reynolds, Geraldine Harriman